dismiss

Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Aktueller Standort:
>
> This Story


Log in oder Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Cardiology Homepage

Israeli researchers develop first 3D heart from patient's biological materials A first — complete with blood vessels, ventricles and cells

Using comic illustrations to support patient understanding of cardiac catheterization Making patients more satisfied, less anxious and more informed

Medical community finds ways to make TAVR safer for at-risk patients Improving outcomes with special procedures

New ultrasound tech could help detect pediatric congenital heart disease Visualizes structure and blood flow of babies' hearts

Mick Jagger resting after TAVR heart surgery The 75 year old rock star is reportedly recovering from the operation at New York Presbyterian

DHS warns some Medtronic implantable defibrillators vulnerable to hacking Software patch should resolve issue, recall not expected

New AI software identifies make and model of cardiac implants in seconds Speed up diagnosis and delivery of treatment for patients with faulty devices

Getting to the heart of cardiac ultrasound technology From premium systems to point of care, an expanding market

FDA gives thumbs-up to Genetesis MCG cardiac imaging system Measures magnetic fields produced by heart's electrical activity

Apple study suggests wearable technology may be useful in detecting atrial fibrillation May assist in stroke and hospitalization prevention

Image of Edwards SAPIEN Transcatheter
Heart Valve

Early discharge associated with better outcomes after TAVR

by Lauren Dubinsky , Senior Reporter
It’s obvious that early discharge is beneficial from a financial standpoint, but it might also have clinical benefits.

New research presented at Society for Cardiovascular Angiography and Interventions 2018 Scientific Sessions late last week found that patients whose hospital stay exceeded 72 hours when undergoing transfemoral TAVR (TF-TAVR) experienced negative short- and long-term outcomes.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



Dr. Siddharth Wayangankar of the University of Florida led this study, which investigated the trend predictors and outcomes associated with hospital length of stay (LOS) following TF-TAVR.

The study included 24,285 patients who underwent non-aborted TF-TAVR and survived discharge from 2011 to 2015. They were categorized as early discharge, which meant their LOS was less than 72 hours, or delayed discharge.

Wayangankar and his team observed that there was a significant decline in the rates of delayed discharge during the study period — 62.2 percent in 2012 Q1 versus 34.4 percent in 2015 Q3.

They compared one-year outcomes based on LOS and found that delayed discharge was significantly associated with higher one-year all-cause mortality. Even after adjusting for in-hospital complications, delayed discharge was still an independent predictor of one-year all-cause mortality.

The findings also revealed distinct independent predictors of early and late discharge. Wayangankar believes that these predictors could have a major impact on the future care of aortic stenosis patients.

Wayangankar told HCB News that the independent predictors of delayed discharge are patients who are over age 85, African-American or Hispanic and those who had prior MC procedures, diabetes, atrial fibrillation, and dialysis, among other factors.

The independent predictors of early discharge are prior implantation of a permanent pacemaker, implantable cardioverter-defibrillator, coronary artery bypass graft as well as myocardial infarction, smoking history, moderate to severe aortic insufficiency and moderate sedation.

Wayangankar believes that patients with delayed discharges might require a more rigorous follow-up schedule to mitigate the higher mortality and hospitalization rates.

The team noted their data on independent predictors should be prospectively validated within the Transcatheter Valve Therapy Registry. Once that is done, LOS calculators could help to streamline TAVR programs worldwide.

Cardiology Homepage


You Must Be Logged In To Post A Comment

Werben
Erhöhen Sie Ihren Bekanntheitsgrad
Auktionen + Privatverkäufe
Den besten Preis erzielen
Geräte/Geräteteile kaufen
Den günstigsten Preis finden
Daily News
Die neuesten Nachrichten lesen
Übersicht
Alle DOTmed Benutzer durchsuchen
Ethik auf DOTmed
Unseren Ethik-Standard anzeigen
Gold-Parts Verkäufer-Programm
PH-Anfragen erhalten
Gold Service Dealer-Programm
Anfragen empfangen
Gesundheitsdienstleister
Alle Gesundheitsdienstleister-Tools anzeigen
Jobs/Training
Einen Job suchen
Parts Hunter +EasyPay
Angebote für Geräteteile erhalten
Kürzlich zertifiziert
Kürzlich zertifizierte Benutzer anzeigen
Kürzlich bewertet
Kürzlich zertifizierte Benutzer anzeigen
Rental Central
Geräte billiger mieten
Geräte/Geräteteile verkaufen
Das meiste Geld erhalten
Service-Techniker Forum
Hilfe und Beratung finden
Einfache Angebots-Anfrage
Angebote für Geräte erhalten
Virtuelle Messe
Service für Geräte finden
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED